Brunner, A. M., & Steensma, D. P. (2019). Targeting aberrant splicing in myelodysplastic syndromes: Biologic rationale and clinical opportunity. Hematol Oncol Clin North Am.
Chicago Stili AlıntıBrunner, Andrew M., ve David P. Steensma. "Targeting Aberrant Splicing in Myelodysplastic Syndromes: Biologic Rationale and Clinical Opportunity." Hematol Oncol Clin North Am 2019.
MLA AlıntıBrunner, Andrew M., ve David P. Steensma. "Targeting Aberrant Splicing in Myelodysplastic Syndromes: Biologic Rationale and Clinical Opportunity." Hematol Oncol Clin North Am 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..